Rescue, amplification, and large-scale production of helper-dependent adenoviral vectors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cold Spring Harbor Protocols

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1101/pdb.prot5627PMID 21724821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of helper-dependent adenoviral vectors.

  2011cited by this paper
• Helper-Dependent Adenoviral Vectors for Gene Therapy

  2005cited by this paper
• Improved system for helper-dependent adenoviral vector production.

  2003cited by this paper
• Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy.

  2002cited by this paper
• Cre Levels Limit Packaging Signal Excision Efficiency in the Cre/loxP Helper-Dependent Adenoviral Vector System

  2002cited by this paper
• Improvements in adenoviral vector technology: overcoming barriers for gene therapy

  2000cited by this paper
• Instability of adenoviral vectors during transport and its implication for clinical studies

  1999cited by this paper
• High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy

  1999cited by this paper
• A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging

  1997cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996cited by this paper
• Packaging capacity and stability of human adenovirus type 5 vectors

  1993cited by this paper

• In vivo HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention

  2026cites this paper
• In vitro and in vivo expansion of CD33/HBG promoter-edited HSPCs with Mylotarg

  2024cites this paper
• Development and evaluation of helper dependent adenoviral vectors for inner ear gene delivery.

  2023cites this paper
• HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.

  2023cites this paper
• N-terminal eGFP-tagging of rabbit apolipoprotein A-I decreases expression and impairs cholesterol-efflux activity.

  2023cites this paper
• Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development

  2021cites this paper
• VikAD, a Vika site-specific recombinase-based system for efficient and scalable helper-dependent adenovirus production

  2021influential citation
• Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

  2019cites this paper
• ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation

  2019cites this paper
• CaV2.1 α1 Subunit Expression Regulates Presynaptic CaV2.1 Abundance and Synaptic Strength at a Central Synapse.

  2019cites this paper
• A novel region in the CaV2.1 α1 subunit C-terminus regulates fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active zone

  2017cites this paper
• Helper-dependent adenoviral vectors expressing anti-HBV pri-miR sequences from the liver-specific PEPCK promoter

  2017cites this paper
• Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn “On” Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model

  2016cites this paper
• Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.

  2016cites this paper
• Gene targeting in human-induced pluripotent stem cells with adenoviral vectors.

  2014cites this paper
• Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation

  2013influential citation
• Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.

  2013cites this paper
• Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial

  2012cites this paper
• Characterization of helper-dependent adenoviral vectors.

  2011cites this paper